Literature DB >> 30970133

Irlen syndrome: systematic review and level of evidence analysis.

Jordan Da Silva Miyasaka1, Raphael V Gonzaga Vieira1, Elaine Shizue Novalo-Goto1, Erik Montagna1, Rubens Wajnsztejn1.   

Abstract

BACKGROUND: Scotopic sensitivity syndrome, later called Meares-Irlen syndrome or simply Irlen syndrome (IS) has been described as symptoms of poor reading ability due to poor color matching and distorted graphic images. Individuals with this syndrome are considered slow, ineffective readers with low comprehension and visual fatigue. It is still uncertain whether the disease pathophysiology is an independent entity or part of the dyslexia spectrum. Nevertheless, treatments with lenses and colored filters have been proposed to alleviate the effect of the luminous contrast and improve patients' reading performance. However, no evidence of treatment effectiveness has been achieved.
OBJECTIVE: The aim of the present study was to obtain evidence about IS etiology, diagnosis and intervention efficacy.
METHODS: A systematic review was performed covering the available studies on IS, assessing the available data according to their level of evidence, focusing on diagnostic tools, proposed interventions and related outcomes.
RESULTS: The data showed high heterogeneity among studies, and lack of evidence on the existence of IS and treatment effectiveness.
CONCLUSION: The syndrome as described, as well as its treatments, require further strong evidence.

Entities:  

Year:  2019        PMID: 30970133     DOI: 10.1590/0004-282X20190014

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Controversial treatment using coloured overlays in visual processing disorders.

Authors:  Jayaprakash Patil
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

2.  The Use of Chromagen Lenses in Different Ocular and Non-ocular Conditions: A Prospective Cohort Study.

Authors:  Zainab Alkhudairy; Fatemah Al Shamlan
Journal:  Cureus       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.